Alvogen
is a New Jersey-based pharmaceutical company that develops, manufactures and supplies OTC medicinal products for the healthcare industry... Read moreAlvogen
is a New Jersey-based pharmaceutical company that develops, manufactures and supplies OTC medicinal products for the healthcare industry... Read more
2009
2836 NAICS listing
News
Mar 10, 2025
GlobalNewswire
Press Release: AEMH : Alvogen Completes Comprehensive Refinancing with Longer-Dated Maturity Profile and Reduction of Debt
Mar 10, 2025
FinanzNachrichten
AEMH: Aztiq Consulting ehf.: Alvogen Completes Comprehensive Refinancing with Longer-Dated Maturity Profile and Reduction of Debt
Mar 07, 2025
Private Equity Wire
Alvogen: Alvogen secures private credit loan from Centerbridge
Jan 31, 2025
PR Newswire
Press Release: AEMH : Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Jun 20, 2024
FinanzNachrichten
AEMH: Bausch Health Companies Inc.: Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
Feb 12, 2024
PR Newswire
Press Release: AEMH : NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)
Jun 10, 2023
Biospectrum Asia
AEMH: Taiwan-based Lotus Pharma inks $350 M deal for bipolar depression treatment
Jun 06, 2023
Pharamceutical Technology
AEMH: Lotus, NRx and Alvogen team up for S-TRBD therapy NRX-101
Jun 06, 2023
BioSpace
AEMH: NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101
Jun 05, 2023
The Business Journals: Philadelphia
AEMH: NRx signs licensing deal for experimental bipolar depression treatment valued at up to $345M
